Myocardial layer-specific effect of myoblast cell-sheet implantation evaluated by tissue strain imaging

Circulation Journal

Volumn 77, Issue 4, 2013, Pages 1063-1072

  Shudo, Yasuhiro ^a   Miyagawa, Shigeru ^a   Nakatani, Satoshi ^a   Fukushima, Satsuki ^a   Sakaguchi, Taichi ^a   Saito, Atsuhiro ^a   Asanuma, Toshihiko ^a   Kawaguchi, Naomasa ^a   Matsuura, Nariaki ^a   Shimizu, Tatsuya ^b   Okano, Teruo ^b   Sawa, Yoshiki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Cytokines; Heart failure; Strain; Tissue Doppler

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; FIBROBLAST GROWTH FACTOR 2; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MESSENGER RNA; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; IMMUNOHISTOCHEMISTRY; M MODE ECHOCARDIOGRAPHY; MUSCLE STRAIN; MYOBLAST; MYOCARDIAL PERFUSION IMAGING; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SWINE; TISSUE DOPPLER IMAGING;

ANIMALS; FEMALE; MYOBLASTS, SKELETAL; MYOCARDIAL INFARCTION; PERICARDIUM; SWINE; SWINE, MINIATURE; VENTRICULAR FUNCTION, LEFT;

EID: 84875517994     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0615     Document Type: Article

References (39)

1. Menasche P, Hagege AA, Scorsin M, Pouzet B, Desnos M, Duboc D, et al. Myoblast transplantation in heart failure. Lancet 2001; 357: 279-280.
2. Ghostine S, Carrion C, Souza LC, Richard P, Bruneval P, Vilquin JT, et al. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 2002; 106: I131-I136.
3. Hagege AA, Marolleau JP, Vilqiun JT, Alheritiere A, Peyrard S, Duboc D, et al. Skeletal myoblast transplantation in ischemic heart failure: Long-term follow-up of the first phase I cohort of patients. Circulation 2006; 114: I108-I113.
4. Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, Pouzet B, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003; 41: 1078-1083.
5. Miyagawa S, Saito A, Sakaguchi T, Yoshikawa Y, Yamauchi T, Imanishi Y, et al. Impaired myocardium regeneration with skeletal cell sheets: A preclinical trial for tissue-engineered regeneration therapy. Transplantation 2010; 90: 364-372.
6. Miyagawa S, Sawa Y, Sakakida S, Taketani S, Kondoh H, Memon IA, et al. Tissue cardiomyoplasty using bioengineered contractile cardiomyocyte sheets to repair damaged myocardium: Their integration with recipient myocardium. Transplantation 2005; 80: 1586-1595.
7. Memon IA, Sawa Y, Fukushima N, Matsumiya G, Miyagawa S, Taketani S, et al. Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. J Thorac Cardiovasc Surg 2009; 130: 646-653.
8. Sekiya N, Matsumiya G, Miyagawa S, Saito A, Shimizu T, Okano T, et al. Layered implantation of myoblast sheets attenuates adverse cardiac remodeling of the infarcted heart. J Thorac Cardiovasc Surg 2009; 138: 985-993.
9. Miyagawa S, Roth M, Saito A, Sawa Y, Kostin S. Tissue-engineered cardiac constructs for cardiac repair. Ann Thorac Surg 2011; 91: 320-329.
10. Fujita T, Sakaguchi T, Miyagawa S, Saito A, Sekiya N, Izutani H, et al. Clinical impact of combined transplantation of autologous skeletal myoblasts and bone marrow mononuclear cells in patients with severely deteriorated ischemic cardiomyopathy. Surg Today 2011; 41: 1029-1036.
11. Janseens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomized controlled trial. Lancet 2006; 367: 113-121.
12. Maruo T, Nakatani S, Jin Y, Uemura K, Sugimachi M, Ueda-Ishibashi H, et al. Evaluation of transmural distribution of viable muscle by myocardial strain profile and dobutamine stress echocardiography. Am J Physiol Heart Circ Physiol 2007; 292: H921-H927.
13. Hasegawa T, Nakatani S, Kanzaki H, Abe H, Kitakaze M. Heterogeneous onset of myocardial relaxation in subendocardial and subepicardial layers assessed with tissue strain imaging: Comparison of normal and hypertrophied myocardium. J Am Coll Cardiol Img 2009; 2: 701-708.
14. Tanimoto T, Imanishi T, Tanaka A, Yamano T, Kitabata H, Takarada S, et al. Bedside assessment of myocardial viability using transmural strain profile in patients with ST-elevation myocardial infarction: Comparison with cardiac magnetic resonance imaging. J Am Soc Echocardiogr 2009; 22: 1015-1021.
15. Reimer KA, Jennings RB. The 'wavefront phenomenon' of myocardial ischemic death. II: Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979; 40: 633-644.
16. Teramoto N, Koshino K, Yokoyama I, Miyagawa S, Ose T, Zeniya T, et al. Experimental pig model of old myocardial infarction with long survival leading to chronic LV dysfunction and remodeling as evaluated by PET. J Nucl Med 2011; 52: 761-768.
17. Sade LE, Severyn DA, Kanzaki H, Dohi K, Gorcsan J 3rd. Secondgeneration tissue Doppler with angle-corrected color-coed wall displacement for quantitative assessment of regional left ventricular function. Am J Cardiol 2003; 92: 554-560.
18. Hu Q, Wang X, Lee J, Mansoor A, Liu J, Zeng L, et al. Profound bioenergetic abnormalities in peri-infarct myocardial regions. Am J Physiol Heart Circ Physiol 2006; 291: H648-H657.
19. Horiguchi K, Sakakida-Kitagawa S, Sawa Y, Li ZZ, Fukushima N, Shirakura R, et al. Selective chemokine and receptor gene expressions in allografts that develop transplant vasculopathy. J Heart Lung Transplant 2002; 21: 1090-1100.
20. Pagani FD, DerSimonian H, Zawadzka A, Wetzel K, Edge AS, Jacoby DB, et al. Autologous skeletal myoblasts transplanted to ischemiadamaged myocardium in humans: Histological analysis of cell survival and differentiation. J Am Coll Cardiol 2003; 41: 1078-1083.
21. Suzuki K, Murtuza B, Fukushima S, Smolenski RT, Varela-Carver A, Coppen SR, et al. Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: Distribution, dynamics, and influence on cardiac function. Circulation 2004; 110: II225-II230.
22. Toyota E, Matsunaga T, Chilian WM. Myocardial angiogenesis. Mol Cell Biochem 2004; 264: 35-44.
23. Toyota E, Warltier DC, Brock T, Ritman E, Kolz C, O'Malley P, et al. Vascular endothelial growth factor is required for coronary collateral growth in the rat. Circulation 2005; 112: 2108-2113.
24. Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671-674.
25. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-beta type 1 receptors. EMBO J 2002; 21: 1743-1753.
26. Zeng L, Hu Q, Wang X, Mansoor A, Lee J, Feygin J, et al. Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Circulation 2007; 115: 1866-1875.
27. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-845.
28. Nagamatsu T, Fujii T, Kusumi M, Zou L, Yamashita T, Osuga Y, et al. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduce oxygen: An implication for the placental vascular development and the pathology of preeclampsia. Endocrinology 2004; 145: 4838-4845.
29. Munaut C, Lorquet S, Pequeux C, Blacher S, Berndt S, Frankenne F, et al. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast. Hum Reprod 2008; 23: 1407-1415.
30. Hearse DJ, Maxwell L, Saldanha C, Gravin JB. The myocardial vasculature during ischemia and reperfusion: A target for injury and protection. J Mol Cell Cardiol 1993; 25: 759-800.
31. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002; 346: 1948-1953.
32. van Ramshorst J, Atsma DE, Beeres SL, Mollema SA, Ajmone Marsan N, Holman ER, et al. Effect of intramyocardial bone marrow cell injection of left ventricular dyssynchrony and global strain. Heart 2009; 95: 119-124.
33. Buda AJ, Zotz RJ, Gallagher KP. Characterization of the functional border zone around regionally ischemic myocardium using circumferential flow-function maps. J Am Coll Cardiol 1986; 8: 150-158.
34. Homans DC, Asinger R, Elsperger KJ, Erlien D, Sublette E, Mikell F, et al. Regional function and perfusion at the lateral border of ischemic myocardium. Circulation 1985; 71: 1038-1047.
35. Patterson RE, Kirk ES. Analysis of coronary collateral structure, function, and ischemic border zones in pigs. Am J Physiol Heart Circ Physiol 1983; 244: H23-H31.
36. Shudo Y, Matsumiya G, Takeda K, Matsue H, Taniguchi K, Sawa Y. Novel software package for quantifying local circumferential myocardial stress. Int J Cardiol 2011; 17: 134-136.
37. Kainuma S, Taniguchi K, Toda K, Funatsu T, Kondoh H, Nishino M, et al. Restrictive mitral annuloplasty for functional mitral regurgitation. Circ J 2011; 75: 571-579.
38. Takeda K, Matsumiya G, Hamada S, Sakaguchi T, Miyagawa S, Yamauchi T, et al. Left ventricular basal myocardial scarring detected by delayed enhancement magnetic resonance imaging predicts outcomes after surgical therapies for patients with ischemic mitral regurgitation and left ventricular dysfunction. Circ J 2011; 75: 148-156.
39. Saito S, Matsumiya G, Sakaguchi T, Miyagawa S, Yoshikawa Y, Yamauchi T, et al. Risk factor analysis of long-term support with left ventricular assist system. Circ J 2010; 74: 715-722.